STAT3 and neoplasm: In tumor cells and tumor microenvironment, excessive cytokines and functional mutation of kinase pathway members alter the regulation of tyrosine kinase pathway, providing a hyper-phosphorylation status at STAT3- Tyr705, which drives the head-to-tail dimerization and following activation [35,36].